// App-Quantinova.ai

AB0914-PARE (2021) : INFORMATION PREFERENCES ABOUT TREATMENT OPTIONS IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS: A DELPHI CONSENSUS STUDY

Researchers

Presenter

  • J. Spierings

Principal Investigators

  • J. M. Van Laar

Medical Centers

  • University Medical Center Utrecht, Rheumatology & Clinical Immunology, Utrecht, Netherlands

  • Royal Free Hospital and University College London, Centre for Rheumatology and Connective Tissue Diseases and University College Medical School, London, United Kingdom

  • University Medical Center Utrecht, Department of Cardiology, Utrecht, Netherlands

  • Leiden University Medical Center, Biomedical Data Sciences, Leiden, the Netherlands

Locations

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • Methotrexate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved